[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 2, 1932


Author Affiliations

New York. Department of Surgical Research, Cornell University Medical College

JAMA. 1932;99(1):57. doi:10.1001/jama.1932.02740530059031

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —The favorable results obtained by Drs. Milhorat, Techner, and Thomas (Proc. Soc. Exper. Biol. & Med.29:609, 1932) in the treatment of progressive muscular dystrophy with glycine will undoubtedly lead to a more extensive use of this compound in therapy. It seems therefore necessary at this time to call attention to the fact that glycine, also called glycocoll, should not be confused with the photographic developer which is sold under the trade name of glycin. This compound is chemically p-hydroxyphenylaminoacetic acid and is distinctly poisonous.

First Page Preview View Large
First page PDF preview
First page PDF preview